FLT4 Produkte
(Fms-Related Tyrosine Kinase 4 (FLT4))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte FLT4 Kategorien
FLT4 Antikörper
High quality antibodies with extensive validation data.
FLT4 ELISA Kits
Reliable ELISA kits for a wide range of species.
FLT4 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene FLT4 Antikörper
- (5)
- (5)
- (1)
- (7)
- (1)
- (4)
Empfohlene FLT4 ELISA Kits
- (1)
- (1)
- (1)
- (1)
Empfohlene FLT4 Proteine
- (3)
- (3)
- (3)
Neueste Publikationen zu unseren FLT4 Produkten
: "Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease." in: Laboratory investigation; a journal of technical methods and pathology, (2019) (PubMed).: "Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation." in: PLoS ONE, Vol. 14, Issue 5, pp. e0216795, (2019) (PubMed).
: "Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage." in: The Journal of clinical investigation, Vol. 129, Issue 6, pp. 2514-2526, (2019) (PubMed).
: "uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis." in: Nature communications, Vol. 9, Issue 1, pp. 5178, (2019) (PubMed).
: "LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. ..." in: Nature, Vol. 562, Issue 7728, pp. 605-609, (2019) (PubMed).
: "VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis." in: EMBO molecular medicine, Vol. 9, Issue 6, pp. 750-769, (2018) (PubMed).
: "Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 26, Issue 1, pp. 162-172, (2018) (PubMed).
: "Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms." in: Nature communications, Vol. 9, Issue 1, pp. 1296, (2018) (PubMed).
: "Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program." in: Nature communications, Vol. 9, Issue 1, pp. 1511, (2018) (PubMed).
: "Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 201, Issue 1, pp. 215-229, (2018) (PubMed).
Synonyme und alternative Namen zu FLT4
fms related tyrosine kinase 4 (FLT4), FMS-like tyrosine kinase 4 (Flt4), fms-related tyrosine kinase 4 (Flt4), fms-related tyrosine kinase 4 (flt4), AI323512, cb1059, Chy, Flt-4, FLT41, LMPH1A, PCL, VEGFR-3, VEGFR3, Vegfr3Bezeichner auf Proteinebene für FLT4
- FLT-4
- VEGFR-3
- fms-like tyrosine kinase 4
- soluble VEGFR3 variant 1
- soluble VEGFR3 variant 2
- soluble VEGFR3 variant 3
- tyrosine-protein kinase receptor FLT4
- vascular endothelial growth factor receptor 3
- chylous ascites
- receptor protein tyrosine kinase
- vascular endothelial growth factor receptor-3
- FMS-like tyrosine kinase 4
- tyrosine kinase VEGFR-3
- VEGFR3
- expando
- receptor tyrosine kinase Flt4